NCT04482894View on ClinicalTrials.gov

Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

May 9, 2025

Study Completion Date

April 1, 2026

Conditions
Leukemia, AcuteAML, AdultALL, AdultMyelodysplastic Syndromes
Interventions
OTHER

Palliative Care Visits

Regular visits with a palliative (supportive) care specialist

Trial Locations (1)

22903

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER